Abstract:Purpose: The objective of this study was to elucidate the spectrum of brain natriuretic peptide (BNP) expression in hemodialysis patients with euvolemic status and investigate its prognostic significance. Methods: Patients on chronic hemodialysis were enrolled. The normal range of BNP was measured and analyzed in patients with euvolemic status defined by systolic blood pressure and overhydration. Hemodialysis patients were stratified into groups according to BNP expression at baseline and followed up for 57 months, with all-cause mortality and cardiovascular disease-related death being assessed as primary outcomes. Results: BNP significantly correlated with overhydration in all patients (r = 0.255, P = .004). In patients with euvolemic state, the average BNP level was 701 (±645) pg/ml, with a 95% confidence interval (CI) of 500-902 pg/ml. In patients with BNP < 902 pg/ml, systolic blood pressure significantly correlated with overhydration. Elevated BNP expression correlated with an increased risk of cardiovascular mortality (HR = 1.871, per 782 pg/ml increase, P = .008). The patients with continuously high levels of BNP showed significantly increased risk of cardiovascular disease-related death during follow-up (HR = 12.845, P = .005). Conclusion: Predialysis measured BNP levels correlate with volume status, and the common range is from 500 to 902 pg/ml in dialysis patients with euvolemic status. Patients with upregulated BNP expression showed an increased risk of cardiovascular death. Key messages What is already known on this topic The volume management of hemodialysis patients should be judged comprehensively by clinical manifestations and objective examinations. The parameters involved in the evaluation need to be further optimized. What this study adds In hemodialysis patients, BNP serves as an indicator of volume status. Properly hydrated hemodialysis patients typically exhibit BNP levels ranging from 500 to 902 pg/ml, while persistent BNP elevation is associated with increased mortality. How this study might affect research, practice, or policy In clinical practice, BNP can be routinely monitored in hemodialysis patients to provide information for volume adjustment and to identify patients with high mortality risk. The potential advantages of implementing targeted BNP management warrant further investigation through intervention studies.

Relationship Between Atrial Natriuretic Peptide ( ANP ) and Left Ventricular Hypertrophy , Blood Volume in Dialysis Patients

Association of Central Arterial Blood Pressure and Left Ventricular Hypertrophy in Patients with Chronic Kidney Disease

Risk Factors of Left Ventricular Hypertrophy (LVH) and Its Relationship with Blood Volume of Uremic Patients

Relationship between the extent of coronary artery lesions and plasma brain natriuretic peptide

Association of N-Terminal Pro-brain Natriuretic Peptide With Volume Status and Cardiac Function in Hemodialysis Patients

Left Ventricular Geometry and the Levels of Plasma B-type Natriuretic Peptide and Serum Procollagen TypeⅢ in Essential Hypertensive Patients

Effect of dialysis modality on left ventricular hypertrophy in patients with end-stage renal disease

Changes in Brain Natriuretic Peptide Are Correlated with Changes in Global End-Diastolic Volume Index

Variation of brain natriuretic peptide assists with volume management and predicts prognosis of hemodialysis patients

Correlation analysis of N-terminal pro-brain natriuretic peptide in maintenance hemodialysis patients

Brain natriuretic peptide reflects volume status and influences on survival of hemodialysis patients

Cross-sectional Study of NT-pro Brain Natriuretic Peptide and Its Correlation with Heart Remodeling and Function in Maintenance Hemodialysis Patients

Relationship of Serum Amino-Terminal Pro-B-natriuretic Peptide with Cardiovascular Disease and Malnutrition in Patients with Maintenance Hemodialysis

The Association between Echocardiographic Parameters of Heart Failure with Preserved Ejection Fraction and Fluid Status Biomarkers in Hemodialysis Patients

Plasma NT-proBNP Levels Can Predict Cardiac Load in Patients on Maintainence Hemodialysis

Relationship of Adiponectin in Plasma to Brain Natriuretic Peptide and Left Ventricular Mass Index of Patients with Chronic Heart Failure

Cardiac Biomarkers and Left Ventricular Hypertrophy in Asymptomatic Hemodialysis Patients

Correlation Between Atrial Natriuretic Peptide and Renin-Angiotensin-aldosterone System in Congestive Heart Failure

Left Ventricular Mass Index in End-Stage Renal Disease Patients during Hemodialysis and Continuous Ambulatory Peritoneal Dialysis

Associations of B-type natriuretic peptide (BNP) and dialysis vintage with CMRI-derived cardiac indices in stable hemodialysis patients with a preserved left ventricular ejection fraction

Association of vascular endothelial growth factor‐C, plasma angiotensinogen and left ventricular hypertrophy in patients with hemodialysis